ClinicalTrials.gg
Drug

Etirinotecan pegol clinical trials

Also written NKTR-102.

studies test it
10
open now
0
in phase 3
2
first study started
2008

How each study uses etirinotecan pegol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

etirinotecan pegol
2

Development codes

NKTR-102
6

Studies by the year they started

10 studies that test it; most in 2008 (4)

Studies that test etirinotecan pegol, by start year
YearStudies
20084
20112
20121
20131
20141
20161

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
7
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 2

Nektar Therapeutics (8) · Abramson Cancer Center at Penn Medicine (1) · Lawrence Recht (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses etirinotecan pegol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 10

Codes

What other systems call etirinotecan pegol · ClinicalTrials.gg INT006297

  • MeSH (NLM) C581703etirinotecan pegolConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) LJ16641SFTETIRINOTECAN PEGOLConfirmed FDA, NLM
  • NCI Thesaurus C74069Etirinotecan PegolOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.